In clinical practice, women who have had a hysterectomy (uterus removed) typically receive estrogen-only systemic therapy, whereas women with an intact uterus are typically prescribed combined estrogen and progesterone systemic therapy to reduce the risk of endometrial cancer.
high
clinical
Clinical rationale for adding progesterone to estrogen therapy in women with an intact uterus to protect the endometrium.